Showing results (401-410 of 716) with videos related to
Sort By:
Pageof 72
The Journal of Infectious Diseases|October 26, 2014
Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventionsJoyce L Sanchez, Peter W Hunt, Cavan S Reilly, et al.Plos One|February 24, 2017
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasmaKatherine E Schlusser, Christopher Pilcher, Esper G Kallas, et al.Molecular Biology and Evolution|August 12, 2009
Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiensAashish R Jha, Satish K Pillai, Vanessa A York, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIVJulie Frouard, Sushama Telwatte, Xiaoyu Luo, et al.The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.JCI Insight|February 12, 2020
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapyMichael J Peluso, Peter Bacchetti, Kristen D Ritter, et al.Blood|December 26, 2008
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune controlApril L Ferre, Peter W Hunt, J William Critchfield, et al.AIDS (London, England)|January 21, 2015
Select host restriction factors are associated with HIV persistence during antiretroviral therapyMohamed Abdel-Mohsen, Charlene Wang, Matthew C Strain, et al.Plos One|August 15, 2017
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controlsThijs Booiman, Ferdinand W Wit, Arginell F Girigorie, et al.AIDS (London, England)|September 11, 2010
Virologic and immunologic response to HAART, by age and regimen classKeri N Althoff, Amy C Justice, Stephen J Gange, et al.Pageof 72